Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 159,528 shares at $47.78 ($7.6M) on 2022-12-13, disclosed to the SEC on 2022-12-14.
Open-market sale of $7.6M BSX by EVP & Group President, Cardiology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $47.78 | 79,264 | $3.8M | 50.0% |
| 3 | $47.78 | 79,264 | $3.8M | 50.0% |
| Total | $47.48 avg | 159,528 | $7.6M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |